Bernd Clement
Kiel University(DE)Christian-Albrechts-Universität zu Kiel(DE)Clinical Research Center Kiel(DE)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Cancer therapeutics and mechanisms, Drug Transport and Resistance Mechanisms, Nitric Oxide and Endothelin Effects, Eicosanoids and Hypertension Pharmacology
Most-Cited Works
- → Lessons Learned from Marketed and Investigational Prodrugs(2004)378 cited
- → Identification of the Missing Component in the Mitochondrial Benzamidoxime Prodrug-converting System as a Novel Molybdenum Enzyme(2006)181 cited
- → The Soluble Guanylyl Cyclase Inhibitor 1H-[1,2,4]Oxadiazolo[4,3,-a]quinoxalin-1-one Is a Nonselective Heme Protein Inhibitor of Nitric Oxide Synthase and Other Cytochrome P-450 Enzymes Involved in Nitric Oxide Donor Bioactivation(1999)153 cited
- → REDUCTION OFN-HYDROXYLATED COMPOUNDS: AMIDOXIMES (N-HYDROXYAMIDINES) AS PRO-DRUGS OF AMIDINES(2002)115 cited
- → Biochemical and Spectroscopic Characterization of the Human Mitochondrial Amidoxime Reducing Components hmARC-1 and hmARC-2 Suggests the Existence of a New Molybdenum Enzyme Family in Eukaryotes(2010)112 cited
- → Synthesis and Biological Evaluation of 11-Substituted 6-Aminobenzo[]phenanthridine Derivatives, a New Class of Antitumor Agents